News provided by Eli Lilly and Company Mar 05, 2026, 06:00 ET Zepbound (tirzepatide) KwikPen for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share pricing available to employees Flexible benefit designs expand access to obesity treatment while aligning with employer needs and budgets INDIANAPOLIS, March 5, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of its Employer Connect platform, introducing new options to help close the access gap in U.S
If you don't remember missing the dose, don't double it
Lets break down what it is, why it matters and how you can reduce it
This difference in GLP-1R and PCSK9 activity over time would result in suboptimal pharmacology for a dual activity fusion molecule
Together, they promote fat loss while preserving lean muscle and improving overall metabolic wellness.
You might be a great candidate for Lipo B injections if you are: Already in a structured weight-loss program or fitness plan